NEXA PLUS- ascorbic acid, cholecalciferol, .alpha.-tocopherol, pyridoxine, folic acid, biotin, calcium, iron, docusate calcium,

País: Estados Unidos

Língua: inglês

Origem: NLM (National Library of Medicine)

Compre agora

Ingredientes ativos:

ascorbic acid (UNII: PQ6CK8PD0R) (ascorbic acid - UNII:PQ6CK8PD0R), cholecalciferol (UNII: 1C6V77QF41) (cholecalciferol - UNII:1C6V77QF41), .Alpha.-Tocopherol (UNII: H4N855PNZ1) (.Alpha.-Tocopherol - UNII:H4N855PNZ1), pyridoxine (UNII: KV2JZ1BI6Z) (pyridoxine - UNII:KV2JZ1BI6Z), Folic Acid (UNII: 935E97BOY8) (Folic Acid - UNII:935E97BOY8), Biotin (UNII: 6SO6U10H04) (Biotin - UNII:6SO6U10H04), Calcium (UNII: SY7Q814VUP) (Calcium - UNII:SY7Q814VUP), Iron (UNII: E1UOL152H7) (Iron - UNII:E1UOL152H7), Docusate C

Disponível em:

Vertical Pharmaceuticals, LLC

DCI (Denominação Comum Internacional):

ascorbic acid

Composição:

ascorbic acid 28 mg

Via de administração:

ORAL

Indicações terapêuticas:

Nexa® Plus Capsules are indicated to provide vitamin/mineral and plant-based DHA supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Nexa® Plus may be useful in improving the nutritional status of women prior to conception. Nexa® Plus Capsules are contraindicated in patients with a known hypersensitivity to any of the ingredients. Do not take this product if you are presently taking mineral oil, unless directed by a doctor.

Resumo do produto:

Nexa® Plus Capsules are available as opaque brown, oblong capsules imprinted "0374" and are available in 30-count bottles (NDC 68025-064-30). KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Vertical Pharmaceuticals, LLC at 1-877-95-VERTI (1-877-958-3784). Store at 20° – 25°C (68° – 77° F). [See USP Controlled Room Temperature.]

Status de autorização:

Dietary Supplement

Características técnicas

                                NEXA PLUS- ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL,
PYRIDOXINE, FOLIC ACID, BIOTIN,
CALCIUM, IRON, DOCUSATE CALCIUM, AND CRYPTHECODINIUM COHNII DHA OIL
CAPSULE
VERTICAL PHARMACEUTICALS, LLC
----------
NEXA PLUS CAPSULES
RX ONLY
Rx Prenatal Vitamin with Plant-Based DHA from Algal Oil
1.25 mg Folic Acid and 350 mg DHA (key omega-3 fatty acid)
Essential vitamins and minerals
Gentle stool softener
DESCRIPTION
Nexa
Plus Capsules are a prescription prenatal / postnatal multivitamin /
mineral softgel capsule with
plant-based DHA. Nexa
Plus Capsules are available as opaque brown, oblong capsules imprinted
"0374" and are available in 30-count bottles (NDC 68025-064-30).
*
†
EACH SOFTGEL CAPSULE CONTAINS:
Vitamin C (ascorbic acid, USP)
28 mg
Vitamin D (cholecalciferol, USP)
800 IU
Vitamin E (d-alpha tocopherol, USP)
30 IU
Vitamin B (pyridoxine hydrochloride, USP)
25 mg
Folic Acid, USP
1.25 mg
Biotin
250 mcg
Calcium
160 mg
Iron (ferrous fumarate, USP)
29 mg
Algal oil blend (derived from Crypthecodinium cohnii)
660 mg
Docusate Calcium, USP
55 mg
OTHER INGREDIENTS:
Ascorbyl palmitate, corn oil, ethyl vanillin, FD&C Yellow #6, FD&C Red
#40, FD&C Blue #1, gelatin,
glycerin, lecithin, soybean oil, sunflower oil, titanium dioxide,
water, yellow beeswax, white ink
(ammonium hydroxide, isopropyl alcohol, n-butyl alcohol, propylene
glycol, shellac glaze in SD-45
alcohol, simethicone, titanium dioxide).
CONTAINS: Soy
INDICATIONS
Nexa
Plus Capsules are indicated to provide vitamin/mineral and plant-based
DHA supplementation
throughout pregnancy, during the postnatal period for both lactating
and non-lactating mothers, and
throughout the childbearing years. Nexa
Plus may be useful in improving the nutritional status of
women prior to conception.
CONTRAINDICATIONS
®
®
®
158 mg calcium from calcium carbonate, USP and 2 mg calcium from
docusate calcium, USP
Providing 350 mg DHA (docosahexaenoic acid)
3
6
*
†
®
®
®
Nexa
Plus Capsules are contraindicated in patients with a known
hypersensitivity to any of the
ingredient
                                
                                Leia o documento completo